Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Beaugerie, Laurent"'
Autor:
Kirchgesner, Julien, Beaugerie, Laurent, Carrat, Fabrice, Andersen, Nynne Nyboe, Jess, Tine, Schwarzinger, Michaël, BERENICE study group, Rahier, Jean-François
Publikováno v:
Gut, Vol. 67, no. 7, p. 1261-1268 (2018)
Gut
Gut, BMJ Publishing Group, 2018, 67 (7), pp.1261-1268. ⟨10.1136/gutjnl-2017-314015⟩
Gut, 2018, 67 (7), pp.1261-1268. ⟨10.1136/gutjnl-2017-314015⟩
Gut
Gut, BMJ Publishing Group, 2018, 67 (7), pp.1261-1268. ⟨10.1136/gutjnl-2017-314015⟩
Gut, 2018, 67 (7), pp.1261-1268. ⟨10.1136/gutjnl-2017-314015⟩
ObjectiveMagnitude and independent drivers of the risk of acute arterial events in IBD are still unclear. We addressed this question in patients with IBD compared with the general population at a nationwide level.DesignUsing the French National Hospi
Autor:
Rosenzwajg M; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France., Lorenzon R; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France., Cacoub P; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.; Department of Internal Medicine and Clinical Immunology, AP-HP, Pitié-Salpêtrière Hospital, Paris, France., Pham HP; ILTOO Pharma, Paris, France., Pitoiset F; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France., El Soufi K; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France., RIbet C; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France., Bernard C; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France., Aractingi S; Department of Dermatology, AP-HP Cochin Hospital, Paris, France., Banneville B; Department of Rheumatology, AP-HP Pitié-Salpêtrière Hospital, Paris, France., Beaugerie L; Department of Gastroenterology, AP-HP Saint Antoine Hospital, Paris, France., Berenbaum F; Department of Rheumatology, AP-HP Saint-Antoine Hospital, Paris, France., Champey J; Department of Rheumatology, AP-HP Saint-Antoine Hospital, Paris, France., Chazouilleres O; Department of Hepatology, AP-HP Saint-Antoine Hospital, Paris, France., Corpechot C; Department of Hepatology, AP-HP Saint-Antoine Hospital, Paris, France., Fautrel B; Department of Rheumatology, AP-HP Pitié-Salpêtrière Hospital, Paris, France., Mekinian A; Department of Internal Medicine, AP-HP, Saint-Antoine Hospital, Paris, France., Regnier E; Department of Dermatology, AP-HP Cochin Hospital, Paris, France., Saadoun D; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.; Department of Internal Medicine and Clinical Immunology, AP-HP, Pitié-Salpêtrière Hospital, Paris, France., Salem JE; Department of Pharmacology and CIC-1421, AP-HP Pitié-Salpêtrière Hospital, Paris, France., Sellam J; Department of Rheumatology, AP-HP Saint-Antoine Hospital, Paris, France., Seksik P; Department of Gastroenterology, AP-HP Saint Antoine Hospital, Paris, France., Daguenel-Nguyen A; Department of Pharmacy, AP-HP Saint-Antoine Hospital, Paris, France., Doppler V; ILTOO Pharma, Paris, France., Mariau J; ILTOO Pharma, Paris, France., Vicaut E; Unité de Recherche Clinique and Université Paris, AP-HP Saint Louis/Lariboisière Hospitals, Paris, France., Klatzmann D; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France david.klatzmann@sorbonne-universite.fr.; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2019 Feb; Vol. 78 (2), pp. 209-217. Date of Electronic Publication: 2018 Nov 24.